In Vitro microRNA Expression Profile Alterations under CDK4/6 Therapy in Breast Cancer

In Vitro microRNA Expression Profile Alterations under CDK4/6 Therapy in Breast Cancer

Background: Breast cancer is the most common type of cancer worldwide. Cyclin-dependent kinase inhibition is one of the backbones of metastatic breast cancer therapy. However, there are a significant number of therapy failures. This study evaluates the biomarker potential of microRNAs for the predic...

Full description

Bibliographic Details
Main Authors: Jasmin Asberger, Kai Berner, Anna Bicker, Marius Metz, Markus Jäger, Daniela Weiß, Clemens Kreutz, Ingolf Juhasz-Böss, Sebastian Mayer, Isabell Ge, Thalia Erbes
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Biomedicines
Subjects:
microRNAs
circulating microRNAs
urinary microRNAs
CDK inhibitor
palbociclib
breast cancer
Online Access:https://www.mdpi.com/2227-9059/11/10/2705

Internet

https://www.mdpi.com/2227-9059/11/10/2705

Similar Items